Morizane C - Search Results

1

Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.

Raymond E, Kulke MH, Qin S, Yu X, Schenker M, Cubillo A, Lou W, Tomasek J, Thiis-Evensen E, Xu JM, Croitoru AE, Khasraw M, Sedlackova E, Borbath I, Ruff P, Oberstein PE, Ito T, Jia L, Hammel P, Shen L, Shrikhande SV, Shen Y, Sufliarsky J, Khan GN, Morizane C, Galdy S, Khosravan R, Fernandez KC, Rosbrook B, Fazio N. Raymond E, et al. Among authors: morizane c. Neuroendocrinology. 2018;107(3):237-245. doi: 10.1159/000491999. Epub 2018 Jul 10. Neuroendocrinology. 2018. PMID: 29991024

2

Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients.

Morizane C, Okusaka T, Ito Y, Ueno H, Ikeda M, Takezako Y, Kagami Y, Ikeda H. Morizane C, et al. Oncology. 2005;68(4-6):432-7. doi: 10.1159/000086985. Epub 2005 Jul 14. Oncology. 2005. PMID: 16020973

3

[S-1 monotherapy for pancreatic cancer].

Okusaka T, Ueno H, Ikeda M, Morizane C. Okusaka T, et al. Among authors: morizane c. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:207-12. Gan To Kagaku Ryoho. 2006. PMID: 16898004 Clinical Trial. Japanese.

4

Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer.

Ueno H, Okusaka T, Ikeda M, Morizane C, Ogura T, Hagihara A, Tanaka T. Ueno H, et al. Among authors: morizane c. Jpn J Clin Oncol. 2007 Jul;37(7):515-20. doi: 10.1093/jjco/hym060. Epub 2007 Aug 2. Jpn J Clin Oncol. 2007. PMID: 17675286 Clinical Trial.

5

Prognostic factors in japanese patients with advanced pancreatic cancer treated with single-agent gemcitabine as first-line therapy.

Tanaka T, Ikeda M, Okusaka T, Ueno H, Morizane C, Hagihara A, Iwasa S, Kojima Y. Tanaka T, et al. Among authors: morizane c. Jpn J Clin Oncol. 2008 Nov;38(11):755-61. doi: 10.1093/jjco/hyn098. Epub 2008 Oct 8. Jpn J Clin Oncol. 2008. PMID: 18845521

6

Do recurrent and metastatic pancreatic cancer patients have the same outcomes with gemcitabine treatment?

Hashimoto K, Ueno H, Ikeda M, Kojima Y, Hagihara A, Kondo S, Morizane C, Okusaka T. Hashimoto K, et al. Among authors: morizane c. Oncology. 2009;77(3-4):217-23. doi: 10.1159/000236022. Epub 2009 Sep 4. Oncology. 2009. PMID: 19729980

7

Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.

Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, Tanaka T, Nakachi K, Mitsunaga S, Kojima Y, Hagihara A, Hiraoka N. Iwasa S, et al. Among authors: morizane c. Jpn J Clin Oncol. 2010 Apr;40(4):313-8. doi: 10.1093/jjco/hyp173. Epub 2010 Jan 4. Jpn J Clin Oncol. 2010. PMID: 20047862

8

[Hepatocellular carcinoma].

Kondo S, Ueno H, Morizane C, Okusaka T. Kondo S, et al. Among authors: morizane c. Gan To Kagaku Ryoho. 2010 Jul;37(7):1219-23. Gan To Kagaku Ryoho. 2010. PMID: 20647702 Japanese.

9

[Medical treatment of pancreatic neuroendocrine tumor].

Okusaka T, Ueno H, Morizane C, Kondo S, Yamaguchi T. Okusaka T, et al. Among authors: morizane c. Nihon Rinsho. 2011 Mar;69 Suppl 2:617-20. Nihon Rinsho. 2011. PMID: 21830611 Review. Japanese. No abstract available.

10

Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma.

Terashima T, Morizane C, Hiraoka N, Tsuda H, Tamura T, Shimada Y, Kaneko S, Kushima R, Ueno H, Kondo S, Ikeda M, Okusaka T. Terashima T, et al. Among authors: morizane c. Neuroendocrinology. 2012;96(4):324-32. doi: 10.1159/000338794. Epub 2012 Aug 28. Neuroendocrinology. 2012. PMID: 22572060 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page